With CAGR of 6.4%, Europe Neurological Disorder Drugs Market Is Expected to Rise US$32.0 Bn by 2024
According to the research report, the Europe neurological disorder drugs market was valued at US$18.3 bn in 2015 and is expected to reach a valuation of US$32.0 bn by the end of 2024. During the forecast period of 2016 and 2024, the global market is projected to expand at CAGR of 6.4%.
View full press release